Leucocin A-UAL 187 is a bacteriocin produced by Leuconostoc gelidum UAL 187, a lactic acid bacterium isolated from vacuum-packaged meat. The bacteriocin was purified by ammonium sulfate or acid (pH 2.5) precipitation, hydrophobic interaction chromatography, gel filtration, and reversed-phase high-performance liquid chromatography with a yield of 58% of the original activity. Leucocin A is stable at low pH and heat resistant, and the activity of the pure form is enhanced by the addition of bovine serum albumin. It is inactivated by a range of proteolytic enzymes. The molecular weight was determined by mass spectrometry to be 3,930.3 0.4. Leucocin A-UAL 187 contains 37 amino acids with a calculated molecular weight of 3,932.3. A mixed oligonucleotide (24-mer) homologous to the sequence of the already known N terminus of the bacteriocin hybridized to a 2.9-kb HpaII fragment of a 7.6-MDa plasmid from the producer strain. The fragment was cloned into pUC118 and then subcloned into a lactococcal shuttle vector, pNZ19. DNA sequencing revealed an operon consisting of a putative upstream promoter, a downstream terminator, and two open reading frames flanked by a putative upstream promoter and a downstream terminator. The first open reading frame downstream of the promoter contains 61 amino acids and is identified as the leucocin structural gene, consisting of a 37-amino-acid bacteriocin and a 24-residue N-terminal extension. No phenotypic expression of the bacteriocin was evident in several lactic acid bacteria that were electrotransformed with pNZ19 containing the 2.9-kb cloned fragment of the leucocin A plasmid.
Bacteriocins are antimicrobial peptides or proteins formed by bacteria. The potential applications for bacteriocin-producing lactic acid bacteria in food preservation has stimulated interest in the characterization of these substances. However, maintaining activity during isolation and purification has proved difficult, and the full or partial amino acid sequences of only five such bacteriocins have been reported. The most extensively studied is nisin A (2, 3, 7, 34) , a posttranslationally modified bacteriocin from Lactococcus lactis subsp. lactis. Nisin has been approved for use as a preservative in foods in over 45 countries (9) . It is ribosomally synthesized (6, 10) and is one of a group of lantibiotics that possess lanthionine-or methyllanthionine-containing rings resulting from the attack of cysteine sulfhydryl groups on dehydroalanine or dehydrobutyrine residues (derived from serine or threonine). Partial characterization of lactacin 481 from L. lactis shows that it also contains lanthionine rings, but the full sequence has not yet been published (31) . In contrast, lactocin S from Lactobacillus sake (27) and lactacin F produced by Lactobacillus acidophilus (28) are peptides containing 54 and 57 amino acids, respectively, that do not contain modified amino acids. The bacteriocins in a third group are considerably larger proteins. Helveticin J, generated by Lactobacillus helveticus, has a molecular weight of 37,511 based on its gene sequence (19) . Similarly, caseicin 80 from Lactobacillus casei is estimated to be a 40,000-to 42,000-Da protein based on gel filtration experiments, but the amino acid sequence is not known (33) .
Interest in the antagonistic activity of lactic acid bacteria has resulted in the cloning of several bacteriocin genes. The structural gene for nisin has been cloned and sequenced (6, 10, 20) , but production of active nisin from a cloned piece of DNA has not yet been demonstrated. Analysis of the gene sequence revealed a 57-residue precursor that consists of a 23-residue leader peptide in addition to the 34-residue bacteriocin that is posttranslationally modified (6) . Two bacteriocin genes have been cloned from Lactococcus lactis subsp. cremoris (38) ; in these genes, three open reading frames (ORFs) are present and are organized in an operon. The first two ORFs encode bacteriocin activity and contain 69 and 77 codons, respectively. The third ORF containing 154 codons is essential for immunity. The structural gene encoding helveticin J produced by Lactobacillus helveticus 481 has been cloned, sequenced, and expressed in Lactobacillus acidophilus (19) . Also, the structural gene encoding lactacin F produced by Lactobacillus acidophilus has been cloned; DNA sequence analysis elucidated a 75-amino-acid precursor bacteriocin consisting of a 57-residue bacteriocin and an 18-residue leader peptide (28, 29) .
Leuconostoc species display antimicrobial activity against other lactic acid bacteria (16, 30) , but little is known about the chemical nature of the active compounds. A strain of Leuconostoc gelidum has been reported that inhibits a wide spectrum of lactic acid bacteria, meat spoilage bacteria, and food-related human pathogens, including Listeria monocytogenes (16) . We previously described a bacteriocinlike substance produced by a different strain of L. gelidum that was isolated from meat (17) . We now report the isolation, puri- fication, and properties of this bacteriocin and cloning of the gene for bacteriocin production by L. gelidum UAL 187.
MATERIALS AND METHODS
Cultures and media. Conditions for growth of the bacteriocin producer L. gelidum UAL 187 and the indicator strain Carnobacterium divergens LV13 were as described previously (17) . The semidefined medium CAA used for production of leucocin A-UAL 187 includes the following (per liter of solution): Casamino Acids (Difco Laboratories, Detroit, Mich.), 15 g; yeast extract (BBL Microbiology Products, Cockeysville, Md.), 5 g; D-glucose (BDH Chemicals Ltd., Poole, England), 20 g; dipotassium phosphate (J. T. Baker Chemical Co., Phillipsburg, N.J.), 2 g; Tween 80 (Difco), 1 ml; diammonium citrate (BDH), 2 g; magnesium sulfate (Anachemia, Champlain, N.Y.), 0.1 g; and manganous sulfate (BDH), 0.05 g. The bacterial strains and plasmids used are listed in Table 1 . Escherichia coli was grown in Luria broth or plates (1.5% agar) with 20 mM glucose at 37°C. The selective concentrations of ampicillin and chloramphenicol for growing E. coli were 100 and 12.5 ,ug/ml, respectively. Carnobacteria, lactococci, and leuconostocs were grown in APT broth (Difco) or plates (1.5% agar) at 25°C. Selective concentrations of 5.0 and 2.5 p.g of chloramphenicol per ml were used for carnobacteria and lactococci and for leuconostocs, respectively. Production and purification of leucocin A-UAL 187. An inoculum of 100 ml of an overnight culture of L. gelidum UAL 187 was added to 5 liters of CAA medium, maintained at pH 6.0 with 1 N sodium hydroxide at 22 to 23°C, and gently stirred under an N2 atmosphere (40 ml/min). After 24 h, cells were harvested by centrifugation at 6,000 x g for 15 min at 4°C. The active substance was precipitated with 70% ammonium sulfate or by lowering the pH to 2.5 with 12 N HCI. The precipitate was dissolved in 6 M urea (Fisher)-10 mM glycine-HCl buffer (pH 2.5) and loaded onto a 6-by 25-cm Amberlite XAD-2 column (BDH). The column was washed with 0.1% trifluoroacetic acid (TFA; 1.5 liters), and with 25% ethanol (1.0 liter), 45% ethanol (1.0 liter), and 75% ethanol (2.0 liters) solutions in 0.1% TFA. Active fractions were pooled, concentrated with a rotary evaporator (s30°C), and loaded onto a Sephadex G-25 (Pharmacia) column (2.5 by 45 cm) equilibrated with 0.1% TFA. The elution (A220) was monitored, and all fractions were assayed for bacteriocin activity. Fractions containing more than 100 arbitrary activity units (AU; determined against C. divergens LV13) of bacteriocin per ml were pooled and concentrated. The sample was purified by high-performance liquid chromatography (HPLC) in a Bio-Rad chromatograph with a reversed-phase C-18 column (8-by 100-mm Waters ,u-Bondapak; 10-p.m particle size, 125 A; pore size, 12.5 nm). Leucocin was isocratically eluted (1.65 ml/min) with 35% acetonitrile-0.15% TFA-H20. The elution (A220) was monitored, the activity was assayed (17) , and the total protein content was determined by using the method of Lowry et al. (24) as modified by Markwell et al. (26) .
Stability of leucocin. The effects of pH, temperature, degradative enzymes, and selected solvents on the activity of leucocin (400 AU/ml) were determined. Pure and crude (after pH precipitation) samples of bacteriocin were suspended in 50 mM glycine-HCl (pH 2.0 and 3.0), 50 mM sodium acetate (pH 4.0 and 5.0), 50 mM sodium citrate (pH 6.0), 60 mM Tris-HCl (pH 7.0 and 8.0), and 50 mM glycineNaOH (pH 9.0 and 10.0). Samples in buffer solutions (200 p.1) were placed on ice and at 25°C and held for 2 and 24 h; one sample in each buffer was placed in boiling water for 20 min, and the residual activity was determined. Samples in buffers at pH 2.0, 6.0, and 10.0 containing 10 mg of bovine serum albumin (BSA; Sigma) per ml or 0.5% dithiothreitol (Sigma) were tested for stability as described above, except that samples containing dithiothreitol were only tested at 0°C.
Enzymes (1 mg/ml) in appropriate buffer solutions were added to purified leucocin (400 AU/ml) suspended in the same buffer solutions, including the following: protease types I, IV, VIII, X, and XIV (Sigma) in 50 mM Tris-HCl (pH 7.5) and type XIII in 50 mM acetate buffer (pH 4.0); trypsin (Sigma) in 50 mM Tris-HCl (pH 7.5); a-and ,-chymotrypsin in 50 mM Tris-HCl and 10 mM CaCl2 (pH 7.5); pepsin in 10 the insert was confirmed by Southern and colony blot hybridization and by restriction analysis. Plasmid pJH8.6L was transformed into Lactococcus lactis Na8, Leuconostoc sp. strain UAL60, and Carnobacterium piscicola UAL26 by electroporation. The presence of pJH8.6L was confirmed by plasmid analysis, restriction analysis, and Southern hybridization. Transformants were confirmed by sugar fermentation testing. Bacteriocin production and immunity were tested by using a deferred inhibition assay (17) .
Nucleotide sequence accession number. The DNA sequence was submitted to Genbank (Los Alamos, N.M.) and was given the accession number M64371.
RESULTS
Purification of leucocin A-UAL 187. The purification stages of leucocin are shown in Table 2 . The recovery of bacteriocin after 70% ammonium sulfate and pH 2.5 precipitation was similar. Each procedure recovered approximately 30 x 106 AU of bacteriocin. The precipitates were not soluble in 50 mM glycine-HCl (pH 2.5); however, the addition of 6 M urea (final concentration) solubilized the precipitate. The crude concentrate was applied to an Amberlite XAD-2 column washed with 0.1% TFA and TFA-ethanol solutions. Bacteriocin was eluted with 75% ethanol-0.1% TFA. Only 4% of the total starting activity was lost in this step. The pooled, active fractions were evaporated, lyophilized, resus- (Fig. 1) ; however, some activity was detected in all subsequent fractions. Only fractions containing more than 100 AU/ml were pooled. Several gradient elutions were tried on an HPLC C-18 column to obtain pure leucocin. Isocratic elution with 35% acetonitrile-0.15% TFA gave the best separation (Fig. 2) . Four fractions corresponding to peaks 1 through 4 were collected; 99% of all activity was detected in peak 2. The HPLC-purified sample was initially visualized by electrophoresis on an SDS-20% polyacrylamide gel (Fig. 3) . Resolution of the small peptides was difficult because they (Fig. 6 ). There is a putative RBS (GAAGG) 7 Fig. 6 ). This has the features associated with a bidirectional rho-independent termination site (32) . The phy, dialysis, and high pH conditions were avoided because they resulted in large losses in activity. Maintaining a low pH and using only precipitation, gel filtration, and hydrophobic interactions resulted in a good yield. Similar yields were obtained when these procedures were used for the isolation of lantibiotics.
In the early stages of the purification process, the bacteriocins aggregate with larger proteins in the supernatant fluids (4, 5) . This may confuse molecular weight determinations (5). Ammonium sulfate and pH precipitations yielded bacteriocin-containing protein aggregates that were not soluble in buffer alone. The addition of urea allowed dissociation of the bacteriocin from the other proteins; upon elution from the Amberlite column, dissociating conditions were no longer necessary. The Sephadex G-25 step resulted in the largest loss of activity. This was unexpected, because gel filtration caused only marginal loss of activity in other studies (4, 5) . This may be explained in part by the fact that only highly active fractions were pooled. All subsequent fractions, however, showed some activity indicating interaction between leucocin A-UAL 187 and the column matrix. The use of TFA as the equilibrating solution may increase the hydrophobicity of the protein and therefore could result increased interaction with the column (37). However, TFA was used because it eliminates the need for dialysis, which was shown to cause large losses of activity in this study.
The stability of leucocin at low pH and its instability at pH 7.0 were similar to those found with other bacteriocins of low molecular weight, such as nisin-A and pediocin AcH (5 methionine is suggested by the consensus distance of 9 bp from the RBS (15) . This extension appears to be proteolytically cleaved before secretion, because the biologically active substance does not contain this region. This leader region may act as a signal sequence; however, it lacks the typically hydrophobic core region and contains four negatively charged residues. A novel excretion mechanism in this group of bacteria may account for these differences from the expected structure of signal peptides (14) . The four amino acids adjacent to the clevage site in the C region (Val-ValGly-Gly) are identical to those of the leader peptide of the lacEF gene of Lactobacillus aCidophilus (29) .
The bacteriocin structural gene may be transcribed from a putative promoter that is located upstream of the lcnA gene. The -10 region (TATAAT) and the first three nucleotides (TTG) of the -35 region follow a conserved pattern, but there is little consensus in the latter three nucleotides (21, 38, 39) . The part of the gene coding for leucocin A-UAL 187 shows no DNA or amino acid homology to the lactacin F gene or to the genes cloned from Lactococcus lactis subsp. cremoris (38) . The apparent operon consisting of a bacteriocin structural gene followed closely by a larger ORF, usually encoding immunity, seems to be a conserved pattern for this type of bacteriocin (29, 38 subcloning of ORF 2 of this putative operon are required to establish the function of this gene. The start codon of this gene is unusual. It is a TTG rather than an ATG. In E. coli, GTG or TTG replaces ATG as a start codon in about 9% of genes (15, 22) . The frequency of this phenomenon in leuconostocs is not known. The putative terminator has a stable stem-loop structure that is preceded by four A's and followed by four U's. This arrangement is characteristic of bidirectional rho-independent terminators (32, 41) .
The position of the lcnA gene within the 2.9-kb insert and the genetic evidence of a putative promoter, immunity gene, and termination signal all indicate that there should be sufficient information to obtain phenotypic expression in a suitable host. However, we were unable to obtain expression of leucocin production or immunity in lactic acid bacteria transformed with pJH8.6L. The expression of the lacF (29) and bacteriocin genes from Lactococcus lactis subsp. cremoris (38) was successful from smaller cloned fragments of 2.2 and 1.8 kb, respectively. In both cases, production and immunity are encoded by closely linked genes. We have not been successful in transforming a bacteriocin-negative mutant of the parent strain. Until we are able to transform the native strain with the clone, we cannot determine whether we have sufficient genetic information for normal phenotypic expression of this bacteriocin.
